Skip to main content

Table 1 Characteristics of patients with a newly diagnosed esophageal or gastric cancer, by different waiting time groups

From: Waiting time for cancer treatment and mental health among patients with newly diagnosed esophageal or gastric cancer: a nationwide cohort study

Characteristics All Waiting time groups
1–8 days 9–17 days 18–29 days 30–60 days >60 days
Number of patients 7080 1733 1542 1556 1601 648
Demographic factors
Age, mean ± SD, years 71.4 ± 11.9 73.7 ± 12.5 70.4 ± 12.2 70.4 ± 11.6 71.1 ± 11.1 70.3 ± 11.1
Gender (% male) 65.7 63.1 67.1 66.3 65.5 69.0
 Material status, n (%)
  Single 914 (12.9) 235 (13.6) 227 (14.7) 180 (11.6) 189 (11.8) 83 (12.8)
  Married 3626 (51.2) 797 (46.0) 806 (52.3) 843 (54.2) 842 (52.6) 338 (52.2)
  Divorce 1158 (16.4) 284 (16.4) 236 (15.3) 242 (15.6) 284 (17.7) 112 (17.3)
  Widow/widower 1368 (19.3) 411 (23.7) 271 (17.6) 288 (18.5) 283 (17.7) 115 (17.8)
  Missing 14 (0.2) 6 (0.3) 2 (0.1) 3 (0.2) 3 (0.2) 0 (0.0)
 Education level, n (%)
   < =9 years 3070 (43.4) 778 (44.9) 655 (42.5) 643 (41.3) 700 (43.7) 294 (45.4)
  10–12 years 2561 (36.2) 586 (33.8) 545 (35.3) 578 (37.2) 600 (37.5) 252 (38.9)
   > =12 years 1038 (14.7) 227 (13.1) 239 (15.5) 255 (16.4) 235 (14.7) 82 (12.7)
  Missing 411 (5.8) 142 (8.2) 103 (6.7) 80 (5.1) 66 (4.1) 20 (3.1)
Disease-related factors
 Time of follow-up (months, until death, emigration or the end of study)
  Mean ± SD 15.6 ± 18.0 10.4 ± 16.1 13.0 ± 15.8 16.3 ± 17.7 18.5 ± 18.0 26.6 ± 21.5
  Hospital Volume       
  Low (<20 cases/year) 3310 (46.8) 975 (56.3) 749 (48.6) 664 (42.7) 659 (41.2) 263 (40.5)
  Median (20–40 cases/year) 1868 (26.4) 442 (25.5) 456 (29.5) 420 (27.0) 387 (24.1) 163 (25.2)
  High (>40 cases/year) 1899 (26.8) 314 (18.1) 337 (21.9) 471 (30.3) 555 (34.7) 222 (34.3)
  Missing 2 (0.0) 0 (0.0) 1 (0.0) 0 (0.0) 0 (0.0) 3 (0.0)
 ASA physical status, n (%)
  I-II 4319 (61.0) 902 (52.1) 970 (62.9) 1023 (65.8) 1030 (64.3) 394 (60.7)
  III-IV 2588 (36.6) 791 (45.6) 529 (34.3) 494 (31.8) 539 (33.7) 235 (36.3)
  Missing 173 (2.4) 40 (2.3) 43 (2.8) 39 (2.4) 32 (2.0) 19 (2.9)
 Cancer type, n (%)
  Gastric cancer 3562 (50.3) 1004 (57.9) 788 (51.1) 737 (47.4) 715 (44.7) 318 (49.1)
  Esophageal cancer 3518 (49.7) 729 (42.1) 754 (48.9) 819 (52.6) 886 (55.3) 330 (50.9)
 Cancer stage, n (%)
  Stage 0 191 (2.70) 24 (1.38) 24 (1.56) 29 (1.86) 52 (3.25) 62 (9.57)
  Stage I 905 (12.8) 131 (7.56) 157 (10.2) 226 (14.5) 260 (16.2) 131 (20.2)
  Stage II 924 (13.1) 155 (8.94) 200 (13.0) 252 (16.2) 236 (14.7) 81 (12.5)
  Stage III 2824 (39.9) 688 (39.7) 601 (39.0) 615 (39.5) 671 (41.9) 249 (38.4)
  Stage IV 2188 (30.9) 726 (41.9) 557 (36.1) 423 (27.2) 369 (23.1) 113 (17.4)
  Missing 48 (0.7) 9 (0.5) 3 (0.2) 11 (0.7) 13 (0.8) 12 (1.9)
 Admission type, n (%)
  GP referral 5406 (76.4) 1071 (61.8) 1128 (73.2) 1303 (83.7) 1367 (85.4) 537 (82.9)
  Emergency intake 1517 (21.4) 627 (36.2) 367 (23.8) 225 (14.5) 201 (12.6) 97 (15.0)
  Missing 157 (2.2) 35 (2.0) 47 (3.0) 28 (1.8) 33 (2.0) 14 (2.1)
 Treatment decided through multidisciplinary conference, n (%)
  Yes 4080 (57.6) 668 (38.6) 929 (60.3) 990 (63.6) 1074 (67.1) 419 (64.7)
  No 2953 (41.7) 1053 (60.8) 599 (38.9) 556 (35.7) 521 (32.5) 224 (34.6)
  Missing 47 (0.7) 12 (0.6) 14 (0.8) 10 (0.7) 6 (0.4) 5 (0.7)
 Planned treatment type, n (%)
  Curative 3038 (42.9) 484 (27.9) 607 (39.4) 783 (50.3) 824 (51.5) 340 (52.5)
  Palliative 2631 (37.2) 714 (41.2) 663 (43.0) 547 (35.2) 548 (34.2) 159 (24.5)
  Supportive 1400 (19.8) 531 (30.6) 271 (17.6) 226 (14.5) 227 (14.2) 145 (22.4)
  Missing 11 (0.1) 4 (0.3) 1 (0.0) 0 (0.0) 2 (0.1) 4 (0.6)
  1. SD standard deviation, ASA American Society of Anesthesiologists